Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Rayner

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|December 24, 2009
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection modelsRajesh V Dudhani, John D Turnidge, Kingsley Coulthard, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairmentMohamed A Kamal, Barbara J Brennan, Vishak Subramoney, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2016
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosaVanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Differential bidirectional transfer of indinavir in the isolated perfused human placentaSreeja Sudhakaran, Hany Ghabrial, Roger L Nation, et al.
Clinical and Translational Science|August 18, 2018
Evaluation of the Cardiac Safety of Long-Acting Endectocide Moxidectin in a Randomized Concentration-QT StudySally A Kinrade, Jay W Mason, Carlos R Sanabria, et al.
Plos Neglected Tropical Diseases|August 5, 2024
The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactationNolan D Wood, Danelle Smith, Sally A Kinrade, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimensStephanie J Wallace, Jian Li, Roger L Nation, et al.
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|December 24, 2009
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection modelsRajesh V Dudhani, John D Turnidge, Kingsley Coulthard, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairmentMohamed A Kamal, Barbara J Brennan, Vishak Subramoney, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2016
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosaVanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Differential bidirectional transfer of indinavir in the isolated perfused human placentaSreeja Sudhakaran, Hany Ghabrial, Roger L Nation, et al.
Clinical and Translational Science|August 18, 2018
Evaluation of the Cardiac Safety of Long-Acting Endectocide Moxidectin in a Randomized Concentration-QT StudySally A Kinrade, Jay W Mason, Carlos R Sanabria, et al.
Plos Neglected Tropical Diseases|August 5, 2024
The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactationNolan D Wood, Danelle Smith, Sally A Kinrade, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimensStephanie J Wallace, Jian Li, Roger L Nation, et al.
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Pageof 7